Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant Placement

NCT: NCT07604142 · ENROLLING_BY_INVITATION

NCT IDNCT07604142
StatusENROLLING_BY_INVITATION
Start Date2025-09-20
Completion2026-11-30

Brief Summary

13 patients will be included in this study with a badly destructed upper molar indicated for extraction. Cone beam computerized tomography images revealed the presence of a large bone defect associated with oro-antral communication with the maxillary sinus. after extraction, The prefabricated allogenic scaffold will be seated. then 6 months later, implant will be inserted.

Frequently Asked Questions

What is Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant Placement?

Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant Placement is a clinical trial registered under NCT07604142. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07604142?

The current status of NCT07604142 (Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant Placement) is: ENROLLING_BY_INVITATION.

When did Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant Placement start?

Allogenic Bone Block for Oro-Antral Communication Closure for Subsequent Implant Placement started on 2025-09-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑